
PRESS KIT
Summary
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Technology Overview
AbCellera’s full-stack, AI-powered drug discovery platform, which integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science, empowers drug developers of all sizes to move quickly, reduce costs, and tackle the toughest problems in drug development.

Quotes





Notable Press Mentions


How AbCellera helps partners propel their antibody therapies to the clinic


AbCellera Continues Partnership Frenzy with AbbVie Antibody Discovery Pact



Rallybio revs up antibody discovery activities with risk-sharing AbCellera pact


Regeneron advances first program from Abcellera collaboration into further preclinical development



A year after embarking on a new HQ and manufacturing site, AbCellera starts second phase of its buildout



Versant biotechs hand AbCellera antibody discovery wish list as part of multiyear deal with the VC shop
Follow Us